Related references
Note: Only part of the references are listed.The HPK1 Inhibitor A-745 Verifies the Potential of Modulating T Cell Kinase Signaling for Immunotherapy
Sven Malchow et al.
ACS CHEMICAL BIOLOGY (2022)
Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1)
Bryan K. Chan et al.
ACS MEDICINAL CHEMISTRY LETTERS (2022)
Development of High-Throughput Assays for Evaluation of Hematopoietic Progenitor Kinase 1 Inhibitors
Brian M. Lacey et al.
SLAS DISCOVERY (2021)
Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
Sreya Bagchi et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 16, 2021 (2021)
Discovery of an Allosteric, Inactive Conformation-Selective Inhibitor of Full-Length HPK1 Utilizing a Kinase Cascade Assay
Weixue Wang et al.
BIOCHEMISTRY (2021)
Identification of Potent Reverse Indazole Inhibitors for HPK1
Elsie C. Yu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2021)
Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1
Andrew P. Degnan et al.
ACS MEDICINAL CHEMISTRY LETTERS (2021)
RNA Dysregulation: An Expanding Source of Cancer Immunotherapy Targets
Yang Pan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds
Brandon A. Vara et al.
ACS MEDICINAL CHEMISTRY LETTERS (2021)
Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based Immunotherapies
Jingwen Si et al.
CANCER CELL (2020)
Critical role of kinase activity of hematopoietic progenitor kinase 1 in anti-tumor immune surveillance
Jinqi Liu et al.
PLOS ONE (2019)
Next generation of immune checkpoint therapy in cancer: new developments and challenges
Julian A. Marin-Acevedo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Combining immune Checkpoint inhibitors with Conventional Cancer Therapy
Yiyi Yan et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Kinase Activity of Hematopoietic Progenitor Kinase 1 Is Essential for the Regulation of T Cell Function
Sairy Hernandez et al.
CELL REPORTS (2018)
De-novo and acquired resistance to immune checkpoint targeting
Nicholas L. Syn et al.
LANCET ONCOLOGY (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition
Elizabeth I. Buchbinder et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)
Cancer Immunotherapy: Selected Targets and Small-Molecule Modulators
Hilmar Weinmann
CHEMMEDCHEM (2016)
Acquired resistance to immunotherapy and future challenges
Nicholas P. Restifo et al.
NATURE REVIEWS CANCER (2016)
Big opportunities for small molecules in immuno-oncology
Jerry L. Adams et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Attenuation of T Cell Receptor Signaling by Serine Phosphorylation-mediated Lysine 30 Ubiquitination of SLP-76 Protein
Xiaohong Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Release of serine/threonine-phosphorylated adaptors from signaling microclusters down-regulates T cell activation
Remi Lasserre et al.
JOURNAL OF CELL BIOLOGY (2011)
Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response
Saba Alzabin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Hematopoietic Progenitor Kinase 1 Is a Negative Regulator of Dendritic Cell Activation
Saba Alzabin et al.
JOURNAL OF IMMUNOLOGY (2009)
Hematopoietic progenitor kinase 1 negatively regulates T cell receptor signaling and T cell-mediated immune responses
Jr-Wen Shui et al.
NATURE IMMUNOLOGY (2007)
Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1
R Arnold et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction
MS Jeon et al.
IMMUNITY (2004)
Involvement of hematopoietic progenitor kinase 1 in T cell receptor signaling
P Ling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b
K Bachmaier et al.
NATURE (2000)